Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2012

Open Access 01-12-2012 | Case report

FDG PET/CT and MR imaging of intramuscular myxoma in the gluteus maximus

Authors: Jun Nishio, Masatoshi Naito

Published in: World Journal of Surgical Oncology | Issue 1/2012

Login to get access

Abstract

Intramuscular myxoma is a rare benign soft tissue tumor which may be mistaken for other benign and low-grade malignant myxoid neoplasms. We present the case of a 63-year-old woman with an asymptomatic intramuscular myxoma discovered incidentally on a whole-body F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography. PET images showed a mild FDG uptake (maximum standardized uptake value, 1.78) in the left gluteus maximus. Subsequent magnetic resonance (MR) imaging revealed a well-defined ovoid mass with homogenous low signal intensity on T1-weighted sequences and markedly high signal intensity on T2-weighted sequences. Contrast-enhanced MR images showed heterogeneous enhancement throughout the mass. The diagnosis of intramuscular myxoma was confirmed on histopathology after surgical excision of the tumor. The patient had no local recurrence at one year follow-up. Our case suggests that intramuscular myxoma should be considered in the differential diagnosis of an oval-shaped intramuscular soft tissue mass with a mild FDG uptake.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zoccali C, Teori G, Prencipe U, Erba F: Mazabraud’s syndrome: a new case and review of the literature. Int Orthop. 2009, 33: 605-610. 10.1007/s00264-007-0483-x.PubMedCentralCrossRefPubMed Zoccali C, Teori G, Prencipe U, Erba F: Mazabraud’s syndrome: a new case and review of the literature. Int Orthop. 2009, 33: 605-610. 10.1007/s00264-007-0483-x.PubMedCentralCrossRefPubMed
2.
go back to reference Ho L, Wassef H, Henderson R, Seto J: F-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in left thigh intramuscular myxoma. Clin Nucl Med. 2009, 34: 224-225. 10.1097/RLU.0b013e31819a204a.CrossRefPubMed Ho L, Wassef H, Henderson R, Seto J: F-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in left thigh intramuscular myxoma. Clin Nucl Med. 2009, 34: 224-225. 10.1097/RLU.0b013e31819a204a.CrossRefPubMed
3.
go back to reference Nielsen GP, O’Connell JX, Rosenberg AE: Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol. 1998, 22: 1222-1227. 10.1097/00000478-199810000-00007.CrossRefPubMed Nielsen GP, O’Connell JX, Rosenberg AE: Intramuscular myxoma: a clinicopathologic study of 51 cases with emphasis on hypercellular and hypervascular variants. Am J Surg Pathol. 1998, 22: 1222-1227. 10.1097/00000478-199810000-00007.CrossRefPubMed
4.
go back to reference Murphey MD, McRae GA, Fanburg-Smith JC, Levine AM, Aboulafia AJ: Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings. Radiology. 2002, 225: 215-224. 10.1148/radiol.2251011627.CrossRefPubMed Murphey MD, McRae GA, Fanburg-Smith JC, Levine AM, Aboulafia AJ: Imaging of soft-tissue myxoma with emphasis on CT and MR and comparison of radiologic and pathologic findings. Radiology. 2002, 225: 215-224. 10.1148/radiol.2251011627.CrossRefPubMed
5.
go back to reference Silver WP, Harrelson JM, Scully SP: Intramuscular myxoma: a clinicopathologic study of 17 patients. Clin Orthop Relat Res. 2002, 403: 191-197.CrossRefPubMed Silver WP, Harrelson JM, Scully SP: Intramuscular myxoma: a clinicopathologic study of 17 patients. Clin Orthop Relat Res. 2002, 403: 191-197.CrossRefPubMed
6.
go back to reference Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H: Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch. 2000, 437: 133-137. 10.1007/s004280000217.CrossRefPubMed Okamoto S, Hisaoka M, Ushijima M, Nakahara S, Toyoshima S, Hashimoto H: Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone. Virchows Arch. 2000, 437: 133-137. 10.1007/s004280000217.CrossRefPubMed
7.
go back to reference Delaney D, Diss TC, Presneau N, Hing S, Berisha F, Idowu BD, O’Donnell P, Skinner JA, Tirabosco R, Flanagan AM: GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol. 2009, 22: 718-724. 10.1038/modpathol.2009.32.CrossRefPubMed Delaney D, Diss TC, Presneau N, Hing S, Berisha F, Idowu BD, O’Donnell P, Skinner JA, Tirabosco R, Flanagan AM: GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. Mod Pathol. 2009, 22: 718-724. 10.1038/modpathol.2009.32.CrossRefPubMed
8.
go back to reference Willems SM, Mohseny AB, Balog C, Sewrajsing R, Briaire-de Bruijn IH, Knijnenburg J, Cleton-Jansen AM, Sciot R, Fletcher CD, Deelder AM, Szuhai K, Hensbergen PJ, Hogendoorn PC: Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med. 2009, 13: 1291-1301. 10.1111/j.1582-4934.2009.00747.x.PubMedCentralCrossRefPubMed Willems SM, Mohseny AB, Balog C, Sewrajsing R, Briaire-de Bruijn IH, Knijnenburg J, Cleton-Jansen AM, Sciot R, Fletcher CD, Deelder AM, Szuhai K, Hensbergen PJ, Hogendoorn PC: Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix. J Cell Mol Med. 2009, 13: 1291-1301. 10.1111/j.1582-4934.2009.00747.x.PubMedCentralCrossRefPubMed
9.
go back to reference Nishio J, Iwasaki H, Nabeshima K, Naito M: Cytogenetics and molecular genetics of myxoid soft tissue sarcomas. Genetics Research International. 2011, 2011: 497148-PubMedCentralCrossRefPubMed Nishio J, Iwasaki H, Nabeshima K, Naito M: Cytogenetics and molecular genetics of myxoid soft tissue sarcomas. Genetics Research International. 2011, 2011: 497148-PubMedCentralCrossRefPubMed
10.
go back to reference Bancroft LW, Kransdorf MJ, Menke DM, O’Connor MI, Foster WC: Intramuscular myxoma: characteristic MR imaging features. AJR Am J Roentgenol. 2002, 178: 1255-1259.CrossRefPubMed Bancroft LW, Kransdorf MJ, Menke DM, O’Connor MI, Foster WC: Intramuscular myxoma: characteristic MR imaging features. AJR Am J Roentgenol. 2002, 178: 1255-1259.CrossRefPubMed
11.
go back to reference Nishimoto K, Kusuzaki K, Matsumine A, Seto M, Fukutome K, Maeda M, Hosoi S, Uchida A: Surrounding muscle edema detected by MRI is valuable for diagnosis of intramuscular myxoma. Oncol Rep. 2004, 11: 143-148.PubMed Nishimoto K, Kusuzaki K, Matsumine A, Seto M, Fukutome K, Maeda M, Hosoi S, Uchida A: Surrounding muscle edema detected by MRI is valuable for diagnosis of intramuscular myxoma. Oncol Rep. 2004, 11: 143-148.PubMed
12.
go back to reference Luna A, Martinez S, Bossen E: Magnetic resonance imaging of intramuscular myxoma with histological comparison and a review of the literature. Skeletal Radiol. 2005, 34: 19-28. 10.1007/s00256-004-0848-9.CrossRefPubMed Luna A, Martinez S, Bossen E: Magnetic resonance imaging of intramuscular myxoma with histological comparison and a review of the literature. Skeletal Radiol. 2005, 34: 19-28. 10.1007/s00256-004-0848-9.CrossRefPubMed
13.
go back to reference Singnurkar A, Phancao JP, Chatha DS, Stern J: The appearance of Mazabraud’s syndrome on 18 F-FDG PET/CT. Skeletal Radiol. 2007, 36: 1085-1089. 10.1007/s00256-007-0336-0.CrossRefPubMed Singnurkar A, Phancao JP, Chatha DS, Stern J: The appearance of Mazabraud’s syndrome on 18 F-FDG PET/CT. Skeletal Radiol. 2007, 36: 1085-1089. 10.1007/s00256-007-0336-0.CrossRefPubMed
14.
go back to reference Suzuki R, Watanabe H, Yanagawa T, Sato J, Shinozaki T, Suzuki H, Endo K, Takagishi K: PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med. 2005, 19: 661-670. 10.1007/BF02985114.CrossRefPubMed Suzuki R, Watanabe H, Yanagawa T, Sato J, Shinozaki T, Suzuki H, Endo K, Takagishi K: PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med. 2005, 19: 661-670. 10.1007/BF02985114.CrossRefPubMed
Metadata
Title
FDG PET/CT and MR imaging of intramuscular myxoma in the gluteus maximus
Authors
Jun Nishio
Masatoshi Naito
Publication date
01-12-2012
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2012
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-132

Other articles of this Issue 1/2012

World Journal of Surgical Oncology 1/2012 Go to the issue